Welcome to Evidence Based Retina
Eyes On Eyecare is thrilled to announce our newest channel, Evidence Based Retina, led by internationally recognized retina specialist Rishi P. Singh, MD, FASRS.
New Content
Clinical Studies & Trials
Real-World Use of Aflibercept 8mg in Eyes With nAMD or DME: Analysis of the IRIS Registry
April 14, 2026
Recently Published
CLINICAL STUDIES & TRIALS
Rates and Risk Factors for Submacular Hemorrhage in nAMD Following Anti-VEGF Injections
Join Drs. Singh and Starr as they discuss the rates and risk factors of submacular hemorrhage in neovascular AMD patients undergoing anti-VEGF treatment.
Rishi P. Singh, MD, FASRS, Matthew Starr, MDApril 6, 2026
PRODUCTS & TECHNOLOGY
Unlocking the Potential of Suprachoroidal Space
Join Drs. Singh and Mammo to review the impact of XIPERE on IOP and which patients may glean the most benefit from treatment.
Rishi P. Singh, MD, FASRS, Danny A. Mammo, MDMarch 31, 2026
PRODUCTS & TECHNOLOGY
Photobiomodulation for Retinal Diseases
Join Drs. Singh and Baldwin as they discuss the role of photobiomodulation in retina disease management.
Rishi P. Singh, MD, FASRS, Grace Baldwin, MDMarch 26, 2026
PRODUCTS & TECHNOLOGY
Oculis' DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
CLINICAL STUDIES & TRIALS
Latest Findings from Pegcetacoplan Trials for Geographic Atrophy in AMD
Rishi P. Singh, MD, FASRS, Ferhina S. Ali, MD, MPHFebruary 24, 2026
